(¿Â¶óÀÎ) ´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ 2021³â Á¦16Â÷ Çмú´ëȸ (2ÀÏÂ÷) : 2021-09-03±³À°ÀÏÀÚ : 2021-09-03
±³À°Àå¼Ò : ½Ç½Ã°£ È»ó°ÀÇ
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ) ´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ 2021³â Á¦16Â÷ Çмú´ëȸ (2ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Áø´ÜÀ¯ÀüÇÐȸ
´ã´çÀÚ : Á¤¹Ì¼±
¿¬¶ôó : 02-772-9004
À̸ÞÀÏ :
ksgd.office@gmail.com ±³À°Á¾·ù : Áø´Ü°Ë»çÀÇÇаú
Âü¼®¿¹»óÀοø : 350¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 120,000¿ø
ºñ°í Á¤È¸¿ø 8¸¸¿ø/ ºñȸ¿ø Àü¹®ÀÇ 12¸¸¿ø/ºñȸ¿ø Àü°øÀÇ º´¸®»ç µî 8¸¸¿ø/»ê¾÷°è 15¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-03 webinar.ksgd.org 08:30~09:00 NGS–based MRD monitoring of lymphoid neoplasm ¾È¾Æ¸®(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 09-03 webinar.ksgd.org 09:00~09:30 NGS–based MRD monitoring of myeloid neoplasm ±èÁøÁÖ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 09-03 webinar.ksgd.org 09:30~10:00 Standardized MRD Assay for FLT3-ITD-Mutated AML ±èÇö¿µ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 09-03 webinar.ksgd.org 10:10~10:40 Ion Torrent Genexus (Á¦³Ø¼½º) ÀüÀÚµ¿ NGS ½Ã½ºÅÛÀÇ SARS-CoV-2 º¯ÀÌ ºÐ¼®°ú Oncomine Assays ½ÃÄö½Ì ¹Ú±ÙÁØ(½á¸ðÇǼŻçÀ̾ðƼÇÈ)
±³À°½Ã°£ 09-03 webinar.ksgd.org 10:40~11:10 Neoseq_ACTION, : lessons learned from 1 year experience äÁ¾Èñ(¼¿ï´ëÇб³)
±³À°½Ã°£ 09-03 webinar.ksgd.org 11:10~11:40 ctDNA°Ë»çÀÇ ÀÓ»óÀû¿ë À̽ÂÅÂ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 09-03 webinar.ksgd.org 11:40~12:10 Cell-free DNA methylation analysis for cancer detection ½Å½ÂÈ£(Áö´Ï³Ê½º)
±³À°½Ã°£ 09-03 webinar.ksgd.org 13:00~13:30 À¯ÀüÁúȯ¿¡¼ÀÇ ºÐÀÚÀ¯Àüº¸°í¼ ±èÀ±Á¤(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 09-03 webinar.ksgd.org 13:30~14:00 Á¾¾çÁúȯ¿¡¼ÀÇ ºÐÀÚÀ¯Àüº¸°í¼ ÀÌÁØÇü(³ì½ÊÀÚÀÇ·áÀç´Ü)
±³À°½Ã°£ 09-03 webinar.ksgd.org 14:00~14:30 °¨¿°Áúȯ¿¡¼ÀÇ ºÐÀÚÀ¯Àüº¸°í¼ ÇãÈñÀç(¼º±Õ°üÀÇ´ë)